
ORAMED PHARMACEUTICALS INC
ORMPNASDAQ🏆 #3248 by market capEarnings Nov 12US Equity
$4.36▲ $0.11 (+2.59%)
Live1h—
24h▲ 2.6%
7d▲ 0.7%
14d▲ 9.8%
30d▲ 10.4%
1y▲ 108.6%
🏦Market Cap
$178M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
60
Fair
📊
Analyst Ratings
Price
$4.36
Total
8
Raised
0
Lowered
1
| Institution | Action | Rating | Date |
|---|---|---|---|
Canaccord Genuity | Reiterated | Hold | 2023-05-17 |
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2023-01-17 |
Aegis Capital | Reiterated | Buy | 2022-05-16 |
Cantor Fitzgerald | Reiterated | Overweight | 2022-02-18 |
National Securities Corporation | Reiterated | Buy | 2021-02-09 |
Ladenburg Thalmann | Reiterated | Buy | 2019-09-11 |
FBR Capital | Reiterated | Outperform | 2015-11-19 |
H.C. Wainwright | Reiterated | Buy | 2015-10-01 |
One row per institution, most recent rating